En Es
Categories

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties. Based on the technology platforms of chemiluminescence (CLIA), monotest ELISA, line immunoblot, immunofluorescenc ...
Products Covid-19Summary
Close

Covid-19 Shenzhen YHLO Biotech Co., Ltd.

Clinical Laboratory

SARS-COV-2 Antigen Test
iFlash-2019-nCoV Antigen Test

YHLO iFlash-2019-nCoV Antigen Test applies the chemiluminescent immunosassay (CLIA) for the qualitative detection of SARS-COV-2 antigen in nasal swab or nasopharyngeal swab.
More details

SARS-COV-2 Rapid Antigen Test
UNICELL-2019-nCoV Rapid Antigen Test

YHLO UNICELL-2019-nCoV rapid antigen test utilizes the lateral flow immunofluorescent sandwich assay and provides test result within 15 minutes.
More details

SARS-COV-2 IgM/IgG Rapid Qualitative Test
GLINE-2019-nCoV IgM/IgG Rapid Qualitative Test

YHLO GLINE -2019-nCoV IgM/IgG Rapid Qualitative Test (Colloidal Gold Assay) is a POCT kit for qualitative determination of IgM and IgG antibodies to 2019-nCoV in human whole blood, serum or plasma.
More details

SARS-CoV-2 IgM & IgG CLIA Assays
iFlash 3000 / iFlash 1800 / iModules

YHLO’s IgG and IgM combined detection is a good supplementary diagnostic tool to PCR, which can identify who are immune to COVID-19 after infection in mass population and its titer change can be used to monitor treatment of COVID-19 patients. Together with iFlash fully automation system, manual work and aerosol contamination risk can be reduced. The assays are CE marked, FDA EUA application accepted and legal export qualification obtained.
More details
Close

About Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties. Based on the technology platforms of chemiluminescence (CLIA), monotest ELISA, line immunoblot, immunofluorescence, YHLO has developed hundreds of test items on autoimmunity, reproductive health, diabetes, infection and routine immunochemistry. YHLO is one of the very few suppliers in China for autoimmune instruments and reagents, and has launched China`s first monotest ELISA analyzer – UNION, China`s first ESR analyzer with direct EDTA tube testing – VISION, China`s first high-speed Chemiluminescence System - iFlash 3000 CLIA System (300 T/H), and China`s first autoimmune assays in CLIA, LIA and ELISA platforms. YHLO has also launched Anti-Müllerian Hormone (AMH) dedicated to ELISA and CLIA systems, as well as the world`s first CLIA assays for Inhibin B, Adiponectin, ZnT8A, RA33, etc. In 2020, YHLO launched CLIA assays of SARS-CoV-2 IgM and IgG to aid the diagnosis of COVID-19.
FaceBook Twitter Google+ Linked in
SARS-COV-2 Rapid Antigen Test

SARS-COV-2 Rapid Antigen Test

Model: UNICELL-2019-nCoV Rapid Antigen Test
Request Information

Description:

YHLO UNICELL-2019-nCoV rapid antigen test utilizes the lateral flow immunofluorescent sandwich assay and provides test result within 15 minutes.

Features

Features

• Affordable
• Compact size for easy transportation & storage
• User friendly design
• Minimal laboratory operation
• Complementary panel for other covid-19 related bio-markers (cTnI/CK-MB/Myo, D-Dimer, PCT, CRP) Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Shenzhen YHLO Biotech Co., Ltd. (SARS-COV-2 Rapid Antigen Test)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions